|
It was reported that during a clinical study, the patient received index cardiac ablation on (b)(6) 2026 for ischemic ventricular tachycardia.On (b)(6) 2026, patient experienced left atrial appendage thrombus (ae#1) categorized as moderate and not serious.Relationship to study device is not related and relationship to the index study procedure is possible.The outcome is ongoing.Intervention was medication (apixaban).
|
|
This report is being submitted pursuant to the provisions of 21 cfr, part 803.This report may be based on information which has not been investigated or verified prior to the required reporting date.This report does not reflect a conclusion by biosense webster, inc., or its employees that the report constitutes an admission that the product, biosense webster, inc., or its employees caused or contributed to the potential event described in this report.If information is obtained that was not available for the initial report, a follow-up report will be filed as appropriate.Manufacturer's reference number: (b)(4).
|